Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iradimed (IRMD) Other Operating Expenses (2016 - 2025)

Iradimed (IRMD) has disclosed Other Operating Expenses for 13 consecutive years, with $4.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Operating Expenses rose 22.01% to $4.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $17.3 million, a 20.14% increase, with the full-year FY2024 number at -$3871.0, up 68.96% from a year prior.
  • Other Operating Expenses was $4.6 million for Q3 2025 at Iradimed, up from $4.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $5.2 million in Q2 2023 to a low of $793716.0 in Q1 2023.
  • A 5-year average of $3.4 million and a median of $3.3 million in 2023 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: plummeted 74.14% in 2023, then skyrocketed 382.18% in 2024.
  • Iradimed's Other Operating Expenses stood at $3.1 million in 2021, then grew by 17.43% to $3.7 million in 2022, then fell by 9.16% to $3.3 million in 2023, then soared by 35.69% to $4.5 million in 2024, then grew by 2.5% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Other Operating Expenses are $4.6 million (Q3 2025), $4.0 million (Q2 2025), and $4.2 million (Q1 2025).